Summary: NIO Inc.

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
  • According to MSCI, the company's ESG score for its industry is poor.

Highlights: NIO Inc.

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses: NIO Inc.

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • The company's earnings releases usually do not meet expectations.

Ratings Chart: NIO Inc.

Source: Surperformance

Fundamentals Valuation Revisions of Fundamental Estimates Capi.($)
- - 9.04B
918B
26.72B
23.79B
Average 244.34B
Weighted average by Cap.
See all sector ratings
Investor
-
Trader
ESG MSCI
-

Financials

Sales growth
EPS Growth
Profitability
-
Net margin
Financial Health
-

Valuation

P/E ratio
-
EV/REVENUE
EV/EBITDA
-
PBR
-
Yield
-

Revisions

1 year Revenue revision
4 months Revenue revision
1 months Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analysts' recommendations
4m Revision of opinion
Potential Price Target
4m Target Price Revision
12m Target Price Revision

Business Predictability

Earnings quality
Analyst Coverag
Divergence of analysts' recommendations
Divergence of Target Price
Divergence of analysts' opinions

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes